WELCOME
The 5th international symposium for researchers and clinicians on Wiskott Aldrich Syndrome will take place on October 19th, 2026, in Ferney-Voltaire, France, just near the Geneva Airport, Switzerland. This event will follow the ESID2026 and will enable researchers and clinicians to meet, present, and discuss their work in the area of WAS and WASp research and clinical advances
Meeting participants will gain valuable insights into innovative perspectives in both basic and clinical research. The scientific programme will draw together experts from around the world to discuss breakthroughs in basic research, advances in clinical practice, novel therapeutic approaches and new insights into stem-cell, cellular and gene therapies. An ideal forum to share knowledge, connect with professional colleagues and grow your professional network.
More details about the event will be available soon.
.png)
OUR GOALS
- Expanding WAS and WASp research.
- Bridging the gap between basic and clinical research to speed up applications
- Foster collaboration among researchers.
- Attract young researchers to focus on WAS and WASp
ORGANIZING COMMITTEE
Prof. Fabio Candotti - CHUV, centre hospitalier universitaire vaudois, Lausanne, Switzerland.
Prof. Michael Albert - Dr. von Hauner Children’s Hospital, LMU Munich, Germany.
Prof. Lisa Westerberg - Karolinska institutet, Stockholm, Sweden.
Dr. Francesca Ferrua - San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, Italy.
Prof. Michael Recher - University of Basel, Switzerland.
Dr. Sumathi Iyengar - The Wiskott Aldrich Foundation, USA.
Mr. Amir Kedar - The Wiskott Aldrich Syndrome association (R.A.).
Endorsed by:
